SCORR Marketing, the full-service marketing and communications firm in the health science industry, and the Conference Forum, the presenter of strategic-level life science conferences, will collaborate on the 2020 Clinical Research as a Care Option (CRAACO) conference. The Conference Forum will include key initiatives and thought leaders from the Bridging Clinical Research & Clinical Health Care Collaborative at its CRAACO conference.
“We started the Bridging Collaborative in 2018 to bring all stakeholders together to address the gap between clinical research and health care,” said Cinda Orr, CEO at SCORR. “Moving these discussions to CRAACO means the momentum of the Bridging Collaborative will continue as we persist in exploring ways to put patients at the center of research and care.”
Although the Bridging Collaborative is changing, its key areas of focus will continue to be discussed through the CRAACO conference.
“While CRAACO approaches clinical research as a care option from a different viewpoint, we expect this collaboration will make our event stronger by bringing more voices to the conversation,” said Valerie Bowling, executive director of the Conference Forum. “This enhances our ability to facilitate meaningful discussions that ultimately benefit patients.”
CRAACO will be April 27–28, 2020, in Raleigh-Durham, NC.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.